Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus

<table>The docked conformation of compound 3 with the receptor CDK5/p25 (PDB: 3O0G). Compound 3 is indicated by red color while the most active site of the CDK5 receptor is shown with green color.</table>

International Journal of Endocrinology

fig4

Figure 4

Figure 4: Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus 